Modifies provisions relating to gender transition procedures

HB 1081 prohibits health care providers from performing gender transition surgeries or prescribing cross-sex hormones or puberty-blocking drugs for gender transition to individuals under 18, with exceptions for disorders of sex development. It defines key terms like "biological sex" and "gender transition" to clarify the scope of the restrictions. Violations could result in license revocation for providers, and the bill allows minors (or their legal representatives) to sue providers for damages if they receive prohibited treatments, with a minimum $500,000 damage award and a presumption of harm if infertility occurs. The law includes a temporary exemption for minors already receiving these treatments before August 2023, and expires on August 28, 2027.